Overview
Smart money at a glance
Filings to Sep 27, 2026Net selling: insiders sold $344K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$344K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- 1 awardAwards on record
Key stats
Fundamentals Sep 26- Open
- $15.32
- 52-wk high
- $16.29
- High
- $15.65
- 52-wk low
- $9.39
- Low
- $15.15
- Prev close
- $15.28
- Mkt cap
- $640.2M
- Volume
- 635.5K
- Fwd P/E
- 96.2x
- Beta
- 0.33
- P/S
- 2.0x
- P/B
- 3.8x
- Profit margin
- -11.5%
- Op margin
- -6.5%
- ROE
- -20.8%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about ANGO filings
Are insiders buying or selling AngioDynamics Inc (ANGO) stock?
Net selling: insiders sold $344K and bought $0 of ANGO stock on the open market in the 90 days to Sep 27, 2026, according to SEC Form 4 filings. The largest was Nighan, Warren JR (SVP Quality and Regulatory), who sold $344K. The latest filing was on Jul 31, 2026.
Which members of Congress have traded ANGO recently?
None. No member of Congress disclosed a ANGO trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this ANGO smart-money data?
This summary uses filings available on Sep 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What insiders are doing
Sells (1)
- NW
Nighan Warren Jr
$344K
sold
What Congress is doing
Sells (1)
- DS
$2K
sold
How top traders are positioned
No tracked top-trader positions in ANGO right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 36.4% above what analysts expected.
Earnings per share
-$0.11 expected
Reports Oct 1, 2026, in 4 days
Financials
Is the business strong?
This company is not yet profitable.
- Net margin
- -11.5%
- Forward P/E
- 96.15
- Market cap
- $640M
Valuation
- P/S2.00
- P/B3.75
Quality
- Operating margin-6.5%
- ROE-20.8%
- ROA-5.1%
Growth
- Beta0.33
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace